Please assess the completion status of the following clinical trial:

Trial Title: A Study to Assess the Cholesterol Lowering Effect of an Ezetimibe/Simvastatin Combination Tablet Compared to Another Cholesterol Lowering Drug in Patients With High Cholesterol and With High Cardiovascular Risk (0653A-809)(COMPLETED)

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Participant is currently taking a statin medication for the treatment of high cholesterol~* Participant has an LDL-C level that is greater than or equal to 100 mg/dl and less than or equal to 190 mg/dl~Exclusion Criteria:~* Women who are pregnant or nursing, or women who intend to become pregnant~* Participant has any condition, situation, or is currently taking any medication that might pose a risk to the participant or interfere with participation in the study

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 79 Years
- Healthy Volunteers: f

Study Arms:
- 1 (Type: EXPERIMENTAL): Arm 1: drug
- 2 (Type: ACTIVE_COMPARATOR): Arm 2: active comparator

Based on this trial design, predict the completion outcome and termination type (if applicable).